A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a …

JLA van Vugt, LJM Alferink, S Buettner… - Journal of …, 2018 - Elsevier
Background & Aims Frail patients with low model for end-stage liver disease (MELD) scores
may be under-prioritised. Low skeletal muscle mass, namely sarcopenia, has been …

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a …

JLA van Vugt, LJM Alferink, S Buettner… - Journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Background & aims Frail patients with low model for end-stage liver disease (MELD) scores
may be under-prioritised. Low skeletal muscle mass, namely sarcopenia, has been …

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a …

JLA van Vugt, LJM Alferink, S Buettner… - Journal of …, 2018 - research.rug.nl
BACKGROUND AND AIMS: Frail patients with low MELD scores may be underprioritised.
Low skeletal muscle mass (ie sarcopenia) has been identified as risk factor for waiting list …

[PDF][PDF] A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a …

JLA van Vugt, L Johanna, M Alferink, S Buettner… - 2017 - scholarlypublications …
Background & Aims: Frail patients with low model for endstage liver disease (MELD) scores
may be under-prioritised. Low skeletal muscle mass, namely sarcopenia, has been …

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a …

JLA van Vugt, LJM Alferink, S Buettner… - Journal of …, 2017 - europepmc.org
BACKGROUND & AIMS: Frail patients with low model for end-stage liver disease (MELD)
scores may be under-prioritised. Low skeletal muscle mass, namely sarcopenia, has been …

[引用][C] A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a …

JLA van Vugt, LJM Alferink, S Buettner… - Journal of …, 2018 - cir.nii.ac.jp
A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in
cirrhotic liver transplant candidates: A competing risk analysis in a national cohort | CiNii …

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a …

J van Vugt, LJM Alferink, S Büttner, M Gaspersz… - Journal of …, 2018 - repub.eur.nl
Background & Aims: Frail patients with low model for end-stage liver disease (MELD) scores
may be under-prioritised. Low skeletal muscle mass, namely sarcopenia, has been …

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a …

JLA van Vugt, LJM Alferink, S Buettner… - Journal of …, 2018 - journal-of-hepatology.eu
Background & Aims Frail patients with low model for end-stage liver disease (MELD) scores
may be under-prioritised. Low skeletal muscle mass, namely sarcopenia, has been …

[引用][C] A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a …

JLA van Vugt, LJM Alferink… - Journal of …, 2018 - scholarlypublications …
A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in
cirrhotic liver transplant candidates: A competing risk analysis in a national cohort | Scholarly …

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a …

JLA van Vugt, LJM Alferink, S Buettner… - Journal of …, 2018 - journal-of-hepatology.eu
Background & Aims Frail patients with low model for end-stage liver disease (MELD) scores
may be under-prioritised. Low skeletal muscle mass, namely sarcopenia, has been …